Avero Diagnostics Email Format
Hospitals and Health CareTexas, United States51-200 Employees
Avero Diagnostics is a physician-owned laboratory that provides anatomic pathology, molecular pathology, and clinical laboratory testing for physicians and their patients. It offers subspecialty pathology services in breast, dermatopathology, gynecologic, gastrointestinal, molecular, and urologic disciplines, operating within the hospital and health care sector from its Irving, Texas location. The company has expanded its offerings over time, including the 2022 launch of BD SurePath and Onclarity HPV Assays for women's health and the 2024 introduction of AMBLor for identifying early-stage melanomas at low risk of progression. In 2024, Versant Diagnostics announced an affiliation with Avero Diagnostics, reflecting ongoing collaboration in the field. As a mid-sized organization with a focus on patient care and research, it seeks to contribute to improved healthcare delivery through its specialized testing and partnerships.